NCT00332046View on ClinicalTrials.gov

fMRI Study Comparing BOLD Activation Patterns Using GW679769 In Subjects With Social Anxiety Disorder

PHASE1CompletedINTERVENTIONAL

Enrollment

57

Participants

Timeline

Start Date

January 31, 2006

Conditions

Social Anxiety Disorder

Interventions

DRUG

GW679769

Trial Locations (1)

92093

GSK Investigational Site, La Jolla

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00332046 - fMRI Study Comparing BOLD Activation Patterns Using GW679769 In Subjects With Social Anxiety Disorder | Biotech Hunter | Biotech Hunter